AIRLINK 65.71 Decreased By ▼ -0.19 (-0.29%)
BOP 5.74 Increased By ▲ 0.05 (0.88%)
CNERGY 4.60 Decreased By ▼ -0.05 (-1.08%)
DFML 23.21 Increased By ▲ 0.36 (1.58%)
DGKC 71.40 Increased By ▲ 0.70 (0.99%)
FCCL 20.89 Increased By ▲ 0.54 (2.65%)
FFBL 29.27 Increased By ▲ 0.16 (0.55%)
FFL 9.94 Increased By ▲ 0.01 (0.1%)
GGL 10.16 Increased By ▲ 0.08 (0.79%)
HBL 115.85 Increased By ▲ 0.60 (0.52%)
HUBC 130.20 Increased By ▲ 0.70 (0.54%)
HUMNL 6.72 Increased By ▲ 0.02 (0.3%)
KEL 4.47 Increased By ▲ 0.09 (2.05%)
KOSM 5.09 Increased By ▲ 0.07 (1.39%)
MLCF 37.60 Increased By ▲ 0.64 (1.73%)
OGDC 131.25 Increased By ▲ 0.05 (0.04%)
PAEL 22.76 Increased By ▲ 0.28 (1.25%)
PIAA 26.18 Decreased By ▼ -0.12 (-0.46%)
PIBTL 6.56 Increased By ▲ 0.03 (0.46%)
PPL 112.20 Increased By ▲ 0.08 (0.07%)
PRL 28.35 Decreased By ▼ -0.04 (-0.14%)
PTC 16.28 Increased By ▲ 0.17 (1.06%)
SEARL 57.55 Decreased By ▼ -0.74 (-1.27%)
SNGP 65.95 Increased By ▲ 0.26 (0.4%)
SSGC 11.14 Increased By ▲ 0.12 (1.09%)
TELE 8.91 Decreased By ▼ -0.03 (-0.34%)
TPLP 12.05 Increased By ▲ 0.52 (4.51%)
TRG 69.50 Increased By ▲ 0.26 (0.38%)
UNITY 23.84 Decreased By ▼ -0.11 (-0.46%)
WTL 1.37 Increased By ▲ 0.02 (1.48%)
BR100 7,316 Increased By 11.7 (0.16%)
BR30 24,047 Increased By 97.1 (0.41%)
KSE100 70,479 Increased By 145.5 (0.21%)
KSE30 23,161 Increased By 40.8 (0.18%)

MUMBAI: India said on Sunday it was considering granting an emergency authorisation for a Covid-19 vaccine, particularly for the elderly and people in high-risk workplaces, as the country's number of reported infections passed 4.75 million.

India, which has consistently reported over 1,000 Covid-19 deaths daily this month, has now recorded 78,586 fatalities from the disease. It lags only the United States globally in overall number of infections, but it has been adding more daily cases than the United States since mid-August.

"India is considering emergency authorisation of a Covid-19 vaccination," said Health Minister Harsh Vardhan. "If there is a consensus we may go ahead with it, especially in the case of senior citizens and people working in high-risk settings."

Vardhan said the timeline on Phase III trials could be shortened by giving emergency authorisation, but stressed no corners would be cut in clinical trials and that a vaccine would only be made available when the government could ensure its safety and efficacy. He said no date has been set for a vaccine launch, but added results of trials should be clear by the first quarter of 2021.

Comments

Comments are closed.